I do not think you understood what I was saying. I understand that right now 75 million shares is the current O/S. My point is that the fully diluted number of shares is greater now than in the past. It's possible for AVXL to now go over 100 million shares. That wasn't possible a few years ago.
Personally, the fewer shares the better but I understand the strategy for preventing takeovers. My best guess is that we'll be slightly over 85M shares when Avavex gets its first approval. And right at 100 million when Anavex gets or doesn't get Alzheimer's approval.
A blockbuster drug and a 5+ year runway would give Anavex all sorts of leverage.